Auxilium Health Rebrands as Aeris Biosciences, Focusing on Regenerative Biomaterials
On July 28, 2026, Auxilium Health announced its rebranding to Aeris Biosciences. The company's new identity reflects the evolution of its proprietary bioaerogel platform and reaffirms its mission to restore human health through advanced biomaterials. Aeris' technology is based on a three-dimensional bioaerogel system designed to inhibit bacterial colonization while guiding tissue regeneration across wound repair, bone regeneration, and therapeutic delivery. The rebranding emphasizes the company's commitment to developing materials that actively shape healing environments rather than passively supporting them. Isaiah Kaiser, PhD, Founder and CEO of Aeris Biosciences, stated that the new name reflects a sharper vision for advancing clinical standards with biomaterials that evolve alongside medical progress. The rebranded firm is headquartered at Cleveland Clinic's Global Innovation Center and supported by several key organizations including the National Science Foundation.
Topics: bioaerogel platform biomaterials healthcare innovation